Loperamide for treatment of acute diarrhoea in infants and young children. A double-blind placebo-controlled trial

Clicks: 315
ID: 116553
1995
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
High-dose loperamide reduces stool output and shortens the duration of diarrhoea in infants receiving intravenous fluids for rehydration, but may cause potentially harmful side-effects in a small number of patients. This double-blind placebo-controlled study was undertaken to assess whether loperami …
Reference Key
md1995southloperamide Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bowie MD;Hill ID;Mann MD;;
Journal south african medical journal = suid-afrikaanse tydskrif vir geneeskunde
Year 1995
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8545750
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Infant Clinical Trial Double-Blind Method length of stay diarrhea controlled clinical trial infantile / drug therapy pmid:8545750 m d bowie i d hill m d mann antidiarrheals / administration & dosage* antidiarrheals / adverse effects loperamide / administration & dosage* loperamide / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.